Literature DB >> 6325331

Anti-immunoglobulin inhibits DNA synthesis in Epstein-Barr virus-transformed lymphoblastoid cell lines.

J Gordon, M D Melamed, S C Ley, N C Hughes-Jones.   

Abstract

Antibodies directed against immunoglobulin (anti-Ig) were found to inhibit the spontaneous incorporation of [3H]thymidine by Epstein-Barr virus (EBV) transformed lymphoblastoid cell lines (LCL). The degree of inhibition was variable but could exceed 80% following a 24 hr exposure of cells to anti-Ig. While a short pulse of antibody was sufficient to cause inhibition, maintainance of the effect required the continual presence of anti-Ig in culture. Maximal suppression by anti-Ig of [3H]thymidine uptake was reached between days 3 and 5, but cells eventually escaped from inhibition. For a line coexpressing IgM and IgD at the cell surfaces it was found that antibodies specific for the individual isotypes were equally effective at inducing suppression. Successful inhibition of DNA synthesis by F(ab')2 fragments of anti-Ig demonstrated that the Fc portion was not required for this effect. Anti-Ig immobilized on plastic surfaces was as effective as soluble antibody in inducing suppression. The implications of these findings for the generation of EBV-transformed LCL producing specific antibody are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325331      PMCID: PMC1454584     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

1.  EB virus-induced B lymphocyte cell lines producing specific antibody.

Authors:  M Steinitz; G Klein; S Koskimies; O Makel
Journal:  Nature       Date:  1977-09-29       Impact factor: 49.962

2.  Induction of IgG production in human B lymphoblastoid cell lines with normal human T cells.

Authors:  T Kishimoto; T Hirano; T Kuritani; Y Yamamura; P Ralph; R A Good
Journal:  Nature       Date:  1978-02-23       Impact factor: 49.962

3.  Production of human IgM anti-D in tissue culture by EB-virus-transformed lymphocytes.

Authors:  A W Boylston; B Gardner; R L Anderson; N C Hughes-Jones
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

4.  The regulation of growth and differentiation of a murine B cell lymphoma. II. The inhibition of WEHI 231 by anti-immunoglobulin antibodies.

Authors:  A W Boyd; J W Schrader
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

Review 5.  Regulation of B lymphocyte replication and maturation.

Authors:  F Melchers; J Andersson; C Corbel; M Leptin; W Lernhardt; W Gerhard; J Zeuthen
Journal:  J Cell Biochem       Date:  1982       Impact factor: 4.429

Review 6.  Induction and suppression of polyclonal antibody responses by anti-Ig reagents and antigen-nonspecific helper factors: a comparison of the effects of anti-Fab, anti-IgM, and anti IgD on murine B cells.

Authors:  D C Parker
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

7.  Immunoglobulin expression and synthesis by human haemic cell lines.

Authors:  J Gordon; D Hough; A Karpas; J L Smith
Journal:  Immunology       Date:  1977-04       Impact factor: 7.397

8.  Establishment of anti-TNP antibody-producing human lymphoid lines by preselection for hapten binding followed by EBV transformation.

Authors:  D Kozbor; M Steinitz; G Klein; S Koskimies; O Mäkelä
Journal:  Scand J Immunol       Date:  1979       Impact factor: 3.487

9.  Human helper T cell factor(s) (ThF). II. Induction of IgG production in B lymphoblastoid cell lines and identification of T cell-replacing factor- (TRF) like factor(s).

Authors:  T Teranishi; T Hirano; N Arima; K Onoue
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

10.  The effect of anti-immunoglobulin antibodies on the in vitro proliferation and differentiation of normal and neoplastic murineB cells.

Authors:  P C Isakson; K A Krolick; J W Uhr; E S Vitetta
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

View more
  1 in total

Review 1.  Monoclonal antibodies--therapeutic and diagnostic uses in malignancy.

Authors:  J N Lowder; R Levy
Journal:  West J Med       Date:  1985-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.